3,6,9,12-Tetraoxapentadec-14-ynoic acid

Catalog No.: 
ACJZGA916
CAS No.: 
1694731-93-5
Molecular Formula: 
C11H18O6
Molecular Weight: 
246.26
3,6,9,12-Tetraoxapentadec-14-ynoic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$76.00In stockInquiry
250mg95%$130.00In stockIn stock
1g95%$282.00In stockIn stock
5g95%$859.00In stockIn stock
25g95%$3898.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3,6,9,12-Tetraoxapentadec-14-ynoic acid
IUPAC Name3,6,9,12-tetraoxapentadec-14-ynoic acid
MDL No.MFCD28505518
Molecular FormulaC11H18O6
Molecular Weight246.26
SMILESOC(COCCOCCOCCOCC#C)=O
InChI KeyMJRNNISHHNMYAE-UHFFFAOYSA-N
SynonymAKOS040742470 | 3,6,9,12-tetraoxapentadec-14-yn-1-oic acid | 3,6,9,12-TETRAOXAPENTADEC-14-YNOIC ACID | AT11892 | HY-130563 | 1694731-93-5 | Propargyl-PEG4-CH2CO2H | SCHEMBL18332577 | WS-00375 | BP-22737 | CS-0109176 | 2-[2-[2-(2-prop-2-ynoxyethoxy)ethoxy]
CAS No.1694731-93-5
PubChem CID91757748

Safety Data

Pictogram
Corrosive
Signal Word
Danger
Hazard Statement(s)
H318
Precautionary Statement(s)
P280-P305+P351+P338+P310

Synthetic Route by SureRoute

1. ACJZGA916 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFRIG140 route compound structure diagram
    ACFRIG140888010-02-4In Stock
  2. Then
  3. ACJZGA916 route product structure diagram
    ACJZGA9161694731-93-5In Stock
Inquiry

2. ACJZGA916 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJZGA916 route product structure diagram
    ACJZGA9161694731-93-5In Stock
Inquiry

3. ACJZGA916 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJZGA916 route product structure diagram
    ACJZGA9161694731-93-5In Stock
Inquiry

Comments (0)